Nevertheless, Schnorfeil et al. found that in a part of AML cases relapsing after chemotherapy or allo-SCT despite of PD-1 upregulation on both PB CD4+ and CD8+ T cells, proliferation and cytokine production in these PD-1+ effector T cells remained functionally intact [79]. The gene discussed is CD4; the disease is acute myeloid leukemia.